Latest From Biotech Now

Cheerios Labeling “Has Emboldened, Not Appeased, Anti-technology Activists”

cheerios-115x76

There continues to be buzz in the media over General Mills’s January 2 announcement to source its original Cheerios’ tiny amount of sugar and corn starch from non-GMO crops. The Wall Street Journal published this week an op-ed titled, “General Mills Has a Soggy Idea for Cheerios – by labeling the cereal as non-genetically modified, the company has only emboldened its critics.”Written by Dr. Henry Miller, founding director of the FDA’s Office of Biotechnology, and Read More >

Farmer Gene  |  1 Comment  |  Email This Post
Tags: , , , ,

Join BIO and Fuels America in Voicing Support for the RFS

FuelsAmerica

The Only Existing Transportation Fuel Program to Tackle Climate Change Is in Danger The Fuels America Coalition will be holding a digital “Day of Action” on January 23, seeking out supporters of renewable fuel. The Renewable Fuel Standard (RFS) is the foundation for increasing production and use of renewable fuels in the United States. Renewable fuels reduce our dependence on oil, help diminish our carbon emissions, and provide economic opportunities across the country. But the Read More >

Environmental & Industrial  |  Leave a comment  |  Email This Post
Tags: , , , , ,

Young Invincibles Still Need Flu Shot

Patient

Last Friday, the CDC reported that 35 states are seeing widespread cases of influenza. Young and middle aged adults are getting hit harder than usual this season due to the prevalence of the H1N1 (swine flu) strain, according to the Pittsburgh Post-Gazette. Most years, it’s the very young and very old who are most affected. Unlike 2009, when H1N1 re-emerged after lying dormant for decades, this year’s flu shot does include protection against H1N1. However, Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , , , ,

What’s In Store for Biotechs at this Year’s CEO & Investor Conference

CEO2014_blog copy

In just a few weeks, industry leaders will gather in New York for one of BIO’s largest and most successful events, the 16th Annual BIO CEO & Investor Conference. As we’ve seen at JPMorgan, the extraordinary performance of biotech equities for the past several years has generated a great deal of interest among investors to work with biotech companies to foster innovation in the coming year. This year’s event is shaping up to be even Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , ,

Congress Passes Omnibus Spending Agreement

Jim Greenwood

This week, BIO President and CEO Jim Greenwood praised the Congress for passing the fundingbill for fiscal 2014, which would, among other things, allow the Food and Drug Administration (FDA) to access $85 million in user fees sequestered in 2013. In addition, BIO supports the agreement’s overall funding for: FDA, NIH, the biodefense enterprise; and improved program oversight of the important 340B program.  BIO also strongly supports the language in the bill providing the Department Read More >

Jim's Corner  |  Leave a comment  |  Email This Post
Tags: , , , , , ,